A Patient with Generalized Pustular Psoriasis Successfully Treated with Ixekizumab
Ixekizumab으로 성공적으로 치료된 전신농포건선 1예
- Document Type
- Publications · Journal Article
- Registered DB
- KCI
- Journal Ranking
- KCI Q2
- Journal
- 대한건선학회지20(2) · pp.67 · 2023
- Citation
- KCI 0
- ISSN
- 2384-1176
Authors
- Cha, soobinFirst author부산대학교 의과대학 피부과학교실
- Lee, Gi-Wook부산대학교 의과대학 피부과학교실
- Shin, Jun-Oh부산대학교 의과대학 피부과학교실
- Roh, Dong Young부산대학교 양산병원 피부과
- Kim, Yeona부산대학교 의과대학 피부과학교실
- Sang-Hyeon Won부산대학교 의과대학 피부과학교실
- Jungsoo Lee부산대학교 의과대학 피부과학교실
- Shin, Kihyuk부산대학교 의과대학 피부과학교실
- Kim, Hoon-soo부산대학교
- Ko, Hyun-Chang부산대학교
- Kim, Moon-Bum부산대학교
- Kim, ByungsooCorresponding author부산대학교
Abstract
Generalized pustular psoriasis (GPP) is a rare subtype of psoriasis characterized by aseptic pustules accompanied by systemic symptoms, including fever. Treatment options for GPP include various systemic therapies, such as conventional agents and newer biologic agents targeting cytokines like TNF-α, IL-17, and IL-23. We are presenting a case of a young male patient diagnosed with GPP, who experienced recurrent acute exacerbations despite previous treatment attempts with methotrexate, acitretin, cyclosporine, as well as phototherapy. Following an unsuccessful trial with the previous treatments, the patient was switched to ixekizumab, an IL-17 inhibitor, resulting in marked clinical improvement. This case demonstrates that biological agents can be a viable treatment option for generalized pustular psoriasis that shows an inadequate response to other therapeutic approaches.
Keywords
Identifiers
- KCI
- ART003029578



Login
Back to Publication list